Identification of causal intervention effects under contagion

Abstract Defining and identifying causal intervention effects for transmissible infectious disease outcomes is challenging because a treatment – such as a vaccine – given to one individual may affect the infection outcomes of others. Epidemiologists have proposed causal estimands to quantify effects of interventions under contagion using a two-person partnership model. These simple conceptual models have helped researchers develop causal estimands relevant to clinical evaluation of vaccine effects. However, many of these partnership models are formulated under structural assumptions that preclude realistic infectious disease transmission dynamics, limiting their conceptual usefulness in defining and identifying causal treatment effects in empirical intervention trials. In this paper, we propose causal intervention effects in two-person partnerships under arbitrary infectious disease transmission dynamics, and give nonparametric identification results showing how effects can be estimated in empirical trials using time-to-infection or binary outcome data. The key insight is that contagion is a causal phenomenon that induces conditional independencies on infection outcomes that can be exploited for the identification of clinically meaningful causal estimands. These new estimands are compared to existing quantities, and results are illustrated using a realistic simulation of an HIV vaccine trial.

[1]  M E Halloran,et al.  Study designs for evaluating different efficacy and effectiveness aspects of vaccines. , 1997, American journal of epidemiology.

[2]  Ilya Shpitser,et al.  Modeling Interference Via Symmetric Treatment Decomposition , 2017, 1709.01050.

[3]  Elja Arjas,et al.  Transmission of Pneumococcal Carriage in Families: A Latent Markov Process Model for Binary Longitudinal Data , 2000 .

[4]  Greenwood,et al.  The Statistics of Anti-Typhoid and Anti-Cholera Inoculations, and the Interpretation of Such Statistics in General , 1915, Proceedings of the Royal Society of Medicine.

[5]  M. Halloran,et al.  Exposure efficacy and change in contact rates in evaluating prophylactic HIV vaccines in the field. , 1994, Statistics in medicine.

[6]  Eben Kenah,et al.  Nonparametric survival analysis of epidemic data , 2013 .

[7]  Claudio J. Struchiner,et al.  Design and Analysis of Vaccine Studies , 2009 .

[8]  M. Halloran,et al.  Causal Inference in Infectious Diseases , 1995, Epidemiology.

[9]  D. Rubin Causal Inference Using Potential Outcomes , 2005 .

[10]  C. Viboud,et al.  A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data , 2004, Statistics in medicine.

[11]  J. Pearl,et al.  Causal inference , 2011, Twenty-one Mental Models That Can Change Policing.

[12]  I M Longini,et al.  Statistical inference for infectious diseases. Risk-specific household and community transmission parameters. , 1988, American journal of epidemiology.

[13]  T. VanderWeele,et al.  Components of the indirect effect in vaccine trials: identification of contagion and infectiousness effects. , 2012, Epidemiology.

[14]  Michael G Hudgens,et al.  Causal Inference for Vaccine Effects on Infectiousness , 2012, The international journal of biostatistics.

[15]  M. Halloran,et al.  Design and interpretation of vaccine field studies. , 1999, Epidemiologic reviews.

[16]  I M Longini,et al.  Estimating household and community transmission parameters for influenza. , 1982, American journal of epidemiology.

[17]  Judea Pearl,et al.  Direct and Indirect Effects , 2001, UAI.

[18]  Eben Kenah,et al.  Contact intervals, survival analysis of epidemic data, and estimation of R(0). , 2009, Biostatistics.

[19]  Elizabeth L. Ogburn,et al.  Causal diagrams for interference , 2014, 1403.1239.

[20]  M. Elizabeth Halloran,et al.  Counting Process Models for Infectious Disease Data: Distinguishing Exposure to Infection from Susceptibility , 1996 .

[21]  Semiparametric Methods for Multiple Exposure Mismeasurement and a Bivariate Outcome in HIV Vaccine Trials , 1999, Biometrics.

[22]  Eben Kenah Semiparametric Relative-Risk Regression for Infectious Disease Transmission Data , 2015, Journal of the American Statistical Association.

[23]  J. Robins,et al.  Identifiability and Exchangeability for Direct and Indirect Effects , 1992, Epidemiology.

[24]  B. Cowling,et al.  Individual Correlates of Infectivity of Influenza A Virus Infections in Households , 2016, PloS one.

[25]  T J VanderWeele,et al.  Direct and Indirect Effects for Neighborhood-Based Clustered and Longitudinal Data , 2010, Sociological methods & research.

[26]  Simon Cauchemez,et al.  Investigating Heterogeneity in Pneumococcal Transmission , 2006 .

[27]  Y. Chiba A Simple Method of Measuring Vaccine Effects on Infectiousness and Contagion , 2013 .

[28]  M. Elizabeth Halloran,et al.  Dependent Happenings: a Recent Methodological Review , 2016, Current Epidemiology Reports.

[29]  J. Peiris,et al.  Influenza A Virus Shedding and Infectivity in Households. , 2015, The Journal of infectious diseases.

[30]  J. Robins,et al.  Generation interval contraction and epidemic data analysis. , 2007, Mathematical biosciences.

[31]  David R. Cox Planning of Experiments , 1958 .

[32]  I M Longini,et al.  A discrete-time model for the statistical analysis of infectious disease incidence data. , 1992, Biometrics.

[33]  Tyler J. VanderWeele,et al.  Bounding the Infectiousness Effect in Vaccine Trials , 2011, Epidemiology.

[34]  M E Halloran,et al.  Study designs for dependent happenings. , 1991, Epidemiology.

[35]  M. Akritas Nonparametric Survival Analysis , 2004 .

[36]  Ilya Shpitser,et al.  Causal Inference Under Interference And Network Uncertainty , 2019, UAI.

[37]  T. Francis Evaluation of the 1954 poliomyelitis vaccine field trial; further studies of results determining the effectiveness of poliomyelitis vaccine (Salk) in preventing paralytic poliomyelitis. , 1955, Journal of the American Medical Association.

[38]  Ilya Shpitser,et al.  Identification and Estimation of Causal Effects from Dependent Data , 2018, NeurIPS.

[39]  M E Halloran,et al.  Direct and indirect effects in vaccine efficacy and effectiveness. , 1991, American journal of epidemiology.

[40]  M. Hudgens,et al.  Assessing effects of cholera vaccination in the presence of interference , 2014, Biometrics.

[41]  Forrest W. Crawford,et al.  Risk ratios for contagious outcomes , 2017, Journal of The Royal Society Interface.

[42]  A. Sjölander,et al.  Carryover Effects in Sibling Comparison Designs. , 2016, Epidemiology.

[43]  M. Hudgens,et al.  Toward Causal Inference With Interference , 2008, Journal of the American Statistical Association.

[44]  Tyler J. VanderWeele,et al.  Vaccines, Contagion, and Social Networks , 2014, ArXiv.

[45]  Y. Chiba A note on bounds for the causal infectiousness effect in vaccine trials , 2012 .

[46]  M Elizabeth Halloran,et al.  Design and evaluation of prophylactic interventions using infectious disease incidence data from close contact groups , 2006, Journal of the Royal Statistical Society. Series C, Applied statistics.

[47]  D. Balding,et al.  Analyses of infectious disease data from household outbreaks by Markov chain Monte Carlo methods , 2000 .

[48]  Elizabeth L. Ogburn Challenges to Estimating Contagion Effects from Observational Data , 2017, 1706.08440.

[49]  Elizabeth L. Ogburn,et al.  Causal inference, social networks, and chain graphs. , 2018 .

[51]  C. Fraser,et al.  Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. , 2009, The New England journal of medicine.